nodes	percent_of_prediction	percent_of_DWPC	metapath
Estramustine—ABCB1—Levothyroxine—hypothyroidism	0.142	0.28	CbGbCtD
Estramustine—ABCB1—Liothyronine—hypothyroidism	0.142	0.28	CbGbCtD
Estramustine—ABCB1—Liotrix—hypothyroidism	0.138	0.273	CbGbCtD
Estramustine—CYP3A4—Levothyroxine—hypothyroidism	0.0849	0.168	CbGbCtD
Estramustine—ESR2—seminiferous tubule of testis—hypothyroidism	0.0322	0.149	CbGeAlD
Estramustine—MAP2—nerve—hypothyroidism	0.0132	0.0611	CbGeAlD
Estramustine—Cardiac failure congestive—Liothyronine—hypothyroidism	0.0117	0.0571	CcSEcCtD
Estramustine—Hypernatraemia—Liotrix—hypothyroidism	0.0101	0.049	CcSEcCtD
Estramustine—MAP1A—adrenal cortex—hypothyroidism	0.00894	0.0413	CbGeAlD
Estramustine—MAP1A—heart—hypothyroidism	0.00864	0.0399	CbGeAlD
Estramustine—Acute coronary syndrome—Liothyronine—hypothyroidism	0.00807	0.0393	CcSEcCtD
Estramustine—Myocardial infarction—Liothyronine—hypothyroidism	0.00803	0.0391	CcSEcCtD
Estramustine—MAP1A—gonad—hypothyroidism	0.0074	0.0342	CbGeAlD
Estramustine—MAP1A—pituitary gland—hypothyroidism	0.00722	0.0334	CbGeAlD
Estramustine—ESR2—Nuclear Receptors—THRA—hypothyroidism	0.0066	0.11	CbGpPWpGaD
Estramustine—MAP1A—adrenal gland—hypothyroidism	0.00645	0.0298	CbGeAlD
Estramustine—MAP1A—thyroid gland—hypothyroidism	0.00623	0.0287	CbGeAlD
Estramustine—Tenderness—Liotrix—hypothyroidism	0.00606	0.0295	CcSEcCtD
Estramustine—MAP1A—female gonad—hypothyroidism	0.00602	0.0278	CbGeAlD
Estramustine—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.00575	0.028	CcSEcCtD
Estramustine—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.00575	0.028	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00553	0.0922	CbGpPWpGaD
Estramustine—MAP1A—testis—hypothyroidism	0.00533	0.0246	CbGeAlD
Estramustine—ESR2—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00521	0.087	CbGpPWpGaD
Estramustine—Affect lability—Dextrothyroxine—hypothyroidism	0.00514	0.025	CcSEcCtD
Estramustine—Affect lability—Levothyroxine—hypothyroidism	0.00514	0.025	CcSEcCtD
Estramustine—MAP2—adrenal cortex—hypothyroidism	0.00508	0.0235	CbGeAlD
Estramustine—MAP1A—liver—hypothyroidism	0.00504	0.0233	CbGeAlD
Estramustine—Cardiac arrest—Levothyroxine—hypothyroidism	0.00496	0.0242	CcSEcCtD
Estramustine—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.00496	0.0242	CcSEcCtD
Estramustine—Mood swings—Dextrothyroxine—hypothyroidism	0.00494	0.0241	CcSEcCtD
Estramustine—Mood swings—Levothyroxine—hypothyroidism	0.00494	0.0241	CcSEcCtD
Estramustine—MAP1A—cerebellum—hypothyroidism	0.00493	0.0228	CbGeAlD
Estramustine—MAP2—heart—hypothyroidism	0.00491	0.0227	CbGeAlD
Estramustine—CYP3A4—urine—hypothyroidism	0.00475	0.0219	CbGeAlD
Estramustine—MAP2—cardiovascular system—hypothyroidism	0.00463	0.0214	CbGeAlD
Estramustine—ESR2—Nuclear Receptors—THRB—hypothyroidism	0.00425	0.0709	CbGpPWpGaD
Estramustine—Cardiac failure congestive—Liotrix—hypothyroidism	0.00423	0.0206	CcSEcCtD
Estramustine—MAP2—gonad—hypothyroidism	0.00421	0.0194	CbGeAlD
Estramustine—MAP2—pituitary gland—hypothyroidism	0.0041	0.019	CbGeAlD
Estramustine—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00396	0.0193	CcSEcCtD
Estramustine—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00396	0.0193	CcSEcCtD
Estramustine—Myocardial infarction—Levothyroxine—hypothyroidism	0.00394	0.0192	CcSEcCtD
Estramustine—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00394	0.0192	CcSEcCtD
Estramustine—Cerebrovascular accident—Liotrix—hypothyroidism	0.00392	0.0191	CcSEcCtD
Estramustine—Affect lability—Liotrix—hypothyroidism	0.00378	0.0184	CcSEcCtD
Estramustine—MAP2—adrenal gland—hypothyroidism	0.00367	0.0169	CbGeAlD
Estramustine—MAP2—blood—hypothyroidism	0.00366	0.0169	CbGeAlD
Estramustine—Cardiac arrest—Liotrix—hypothyroidism	0.00365	0.0178	CcSEcCtD
Estramustine—Mood swings—Liotrix—hypothyroidism	0.00364	0.0177	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00356	0.0594	CbGpPWpGaD
Estramustine—MAP2—thyroid gland—hypothyroidism	0.00354	0.0163	CbGeAlD
Estramustine—MAP2—female gonad—hypothyroidism	0.00342	0.0158	CbGeAlD
Estramustine—Estriol—SHBG—hypothyroidism	0.00338	0.291	CrCbGaD
Estramustine—ESR2—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00336	0.0561	CbGpPWpGaD
Estramustine—Flushing—Levothyroxine—hypothyroidism	0.00335	0.0163	CcSEcCtD
Estramustine—Flushing—Dextrothyroxine—hypothyroidism	0.00335	0.0163	CcSEcCtD
Estramustine—ESR1—Nuclear Receptors—THRA—hypothyroidism	0.00333	0.0555	CbGpPWpGaD
Estramustine—Alopecia—Dextrothyroxine—hypothyroidism	0.00319	0.0155	CcSEcCtD
Estramustine—Alopecia—Levothyroxine—hypothyroidism	0.00319	0.0155	CcSEcCtD
Estramustine—ESR2—heart—hypothyroidism	0.00318	0.0147	CbGeAlD
Estramustine—MAP2—testis—hypothyroidism	0.00303	0.014	CbGeAlD
Estramustine—ESR2—cardiovascular system—hypothyroidism	0.003	0.0139	CbGeAlD
Estramustine—Acute coronary syndrome—Liotrix—hypothyroidism	0.00292	0.0142	CcSEcCtD
Estramustine—Myocardial infarction—Liotrix—hypothyroidism	0.0029	0.0141	CcSEcCtD
Estramustine—MAP2—liver—hypothyroidism	0.00287	0.0132	CbGeAlD
Estramustine—MAP2—cerebellum—hypothyroidism	0.0028	0.0129	CbGeAlD
Estramustine—ESR2—gonad—hypothyroidism	0.00273	0.0126	CbGeAlD
Estramustine—Anxiety—Levothyroxine—hypothyroidism	0.00267	0.013	CcSEcCtD
Estramustine—Anxiety—Dextrothyroxine—hypothyroidism	0.00267	0.013	CcSEcCtD
Estramustine—ESR2—pituitary gland—hypothyroidism	0.00266	0.0123	CbGeAlD
Estramustine—ESR1—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00263	0.0439	CbGpPWpGaD
Estramustine—Estropipate—SHBG—hypothyroidism	0.00258	0.223	CrCbGaD
Estramustine—Flushing—Liotrix—hypothyroidism	0.00246	0.012	CcSEcCtD
Estramustine—ESR2—adrenal gland—hypothyroidism	0.00238	0.011	CbGeAlD
Estramustine—ESR2—blood—hypothyroidism	0.00238	0.011	CbGeAlD
Estramustine—Alopecia—Liotrix—hypothyroidism	0.00235	0.0114	CcSEcCtD
Estramustine—Insomnia—Dextrothyroxine—hypothyroidism	0.00232	0.0113	CcSEcCtD
Estramustine—Insomnia—Levothyroxine—hypothyroidism	0.00232	0.0113	CcSEcCtD
Estramustine—ESR2—thyroid gland—hypothyroidism	0.00229	0.0106	CbGeAlD
Estramustine—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00229	0.0111	CcSEcCtD
Estramustine—Dyspnoea—Levothyroxine—hypothyroidism	0.00229	0.0111	CcSEcCtD
Estramustine—Flatulence—Liotrix—hypothyroidism	0.00228	0.0111	CcSEcCtD
Estramustine—ESR2—female gonad—hypothyroidism	0.00222	0.0102	CbGeAlD
Estramustine—ESR1—heart—hypothyroidism	0.00218	0.0101	CbGeAlD
Estramustine—ESR1—Nuclear Receptors—THRB—hypothyroidism	0.00214	0.0358	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00213	0.0356	CbGpPWpGaD
Estramustine—ESR1—cardiovascular system—hypothyroidism	0.00206	0.0095	CbGeAlD
Estramustine—Chest pain—Liotrix—hypothyroidism	0.00197	0.00958	CcSEcCtD
Estramustine—ESR2—testis—hypothyroidism	0.00196	0.00907	CbGeAlD
Estramustine—Anxiety—Liotrix—hypothyroidism	0.00196	0.00955	CcSEcCtD
Estramustine—Oedema—Liotrix—hypothyroidism	0.00189	0.00919	CcSEcCtD
Estramustine—ESR1—gonad—hypothyroidism	0.00187	0.00862	CbGeAlD
Estramustine—ESR2—liver—hypothyroidism	0.00186	0.00858	CbGeAlD
Estramustine—Ethinyl Estradiol—SHBG—hypothyroidism	0.00184	0.159	CrCbGaD
Estramustine—ESR1—pituitary gland—hypothyroidism	0.00182	0.00841	CbGeAlD
Estramustine—Pruritus—Dextrothyroxine—hypothyroidism	0.00181	0.00884	CcSEcCtD
Estramustine—Pruritus—Levothyroxine—hypothyroidism	0.00181	0.00884	CcSEcCtD
Estramustine—ESR2—cerebellum—hypothyroidism	0.00181	0.00838	CbGeAlD
Estramustine—Anorexia—Liotrix—hypothyroidism	0.0018	0.00876	CcSEcCtD
Estramustine—Diarrhoea—Levothyroxine—hypothyroidism	0.00175	0.00855	CcSEcCtD
Estramustine—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00175	0.00855	CcSEcCtD
Estramustine—Insomnia—Liotrix—hypothyroidism	0.00171	0.00831	CcSEcCtD
Estramustine—ESR1—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00169	0.0283	CbGpPWpGaD
Estramustine—Dyspnoea—Liotrix—hypothyroidism	0.00168	0.00819	CcSEcCtD
Estramustine—Decreased appetite—Liotrix—hypothyroidism	0.00164	0.00799	CcSEcCtD
Estramustine—Vomiting—Levothyroxine—hypothyroidism	0.00163	0.00794	CcSEcCtD
Estramustine—Vomiting—Dextrothyroxine—hypothyroidism	0.00163	0.00794	CcSEcCtD
Estramustine—ESR1—adrenal gland—hypothyroidism	0.00163	0.00751	CbGeAlD
Estramustine—ESR1—blood—hypothyroidism	0.00163	0.00751	CbGeAlD
Estramustine—Rash—Dextrothyroxine—hypothyroidism	0.00162	0.00788	CcSEcCtD
Estramustine—Rash—Levothyroxine—hypothyroidism	0.00162	0.00788	CcSEcCtD
Estramustine—Dermatitis—Dextrothyroxine—hypothyroidism	0.00162	0.00787	CcSEcCtD
Estramustine—Dermatitis—Levothyroxine—hypothyroidism	0.00162	0.00787	CcSEcCtD
Estramustine—Headache—Levothyroxine—hypothyroidism	0.00161	0.00783	CcSEcCtD
Estramustine—Headache—Dextrothyroxine—hypothyroidism	0.00161	0.00783	CcSEcCtD
Estramustine—Estrone—SHBG—hypothyroidism	0.00161	0.138	CrCbGaD
Estramustine—ESR1—thyroid gland—hypothyroidism	0.00157	0.00725	CbGeAlD
Estramustine—Nausea—Dextrothyroxine—hypothyroidism	0.00152	0.00742	CcSEcCtD
Estramustine—Nausea—Levothyroxine—hypothyroidism	0.00152	0.00742	CcSEcCtD
Estramustine—ESR1—female gonad—hypothyroidism	0.00152	0.00701	CbGeAlD
Estramustine—MAP2—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00142	0.0237	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—ZNF764—hypothyroidism	0.0014	0.0233	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00137	0.0229	CbGpPWpGaD
Estramustine—ESR1—testis—hypothyroidism	0.00135	0.00621	CbGeAlD
Estramustine—Pruritus—Liotrix—hypothyroidism	0.00133	0.0065	CcSEcCtD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—NKX2-5—hypothyroidism	0.00129	0.0216	CbGpPWpGaD
Estramustine—Diarrhoea—Liotrix—hypothyroidism	0.00129	0.00629	CcSEcCtD
Estramustine—ESR1—liver—hypothyroidism	0.00127	0.00587	CbGeAlD
Estramustine—ESR2—Validated nuclear estrogen receptor alpha network—PRL—hypothyroidism	0.00125	0.0209	CbGpPWpGaD
Estramustine—ESR1—cerebellum—hypothyroidism	0.00124	0.00574	CbGeAlD
Estramustine—Estradiol—SHBG—hypothyroidism	0.00122	0.105	CrCbGaD
Estramustine—Vomiting—Liotrix—hypothyroidism	0.0012	0.00584	CcSEcCtD
Estramustine—Rash—Liotrix—hypothyroidism	0.00119	0.00579	CcSEcCtD
Estramustine—Dermatitis—Liotrix—hypothyroidism	0.00119	0.00579	CcSEcCtD
Estramustine—Headache—Liotrix—hypothyroidism	0.00118	0.00576	CcSEcCtD
Estramustine—Nausea—Liotrix—hypothyroidism	0.00112	0.00546	CcSEcCtD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—IGF1—hypothyroidism	0.00102	0.017	CbGpPWpGaD
Estramustine—Testosterone—SHBG—hypothyroidism	0.000977	0.0842	CrCbGaD
Estramustine—ESR1—Nuclear signaling by ERBB4—PRL—hypothyroidism	0.000938	0.0156	CbGpPWpGaD
Estramustine—CYP3A4—blood—hypothyroidism	0.000908	0.00419	CbGeAlD
Estramustine—ESR2—Generic Transcription Pathway—THRA—hypothyroidism	0.000901	0.015	CbGpPWpGaD
Estramustine—ABCB1—adrenal cortex—hypothyroidism	0.00089	0.00411	CbGeAlD
Estramustine—ABCB1—heart—hypothyroidism	0.000861	0.00398	CbGeAlD
Estramustine—ABCB1—cardiovascular system—hypothyroidism	0.000812	0.00375	CbGeAlD
Estramustine—ABCB1—gonad—hypothyroidism	0.000737	0.00341	CbGeAlD
Estramustine—ABCB1—pituitary gland—hypothyroidism	0.000719	0.00332	CbGeAlD
Estramustine—CYP3A4—liver—hypothyroidism	0.00071	0.00328	CbGeAlD
Estramustine—ESR1—Generic Transcription Pathway—ZNF764—hypothyroidism	0.000705	0.0118	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—ZNF764—hypothyroidism	0.000673	0.0112	CbGpPWpGaD
Estramustine—ABCB1—adrenal gland—hypothyroidism	0.000643	0.00297	CbGeAlD
Estramustine—ABCB1—blood—hypothyroidism	0.000642	0.00297	CbGeAlD
Estramustine—ESR2—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000642	0.0107	CbGpPWpGaD
Estramustine—ESR1—Validated nuclear estrogen receptor alpha network—PRL—hypothyroidism	0.000631	0.0105	CbGpPWpGaD
Estramustine—ABCB1—thyroid gland—hypothyroidism	0.00062	0.00286	CbGeAlD
Estramustine—ABCB1—female gonad—hypothyroidism	0.000599	0.00277	CbGeAlD
Estramustine—ESR2—Generic Transcription Pathway—THRB—hypothyroidism	0.00058	0.00968	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000547	0.00912	CbGpPWpGaD
Estramustine—ABCB1—testis—hypothyroidism	0.000531	0.00245	CbGeAlD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—IGF1—hypothyroidism	0.000513	0.00856	CbGpPWpGaD
Estramustine—ABCB1—liver—hypothyroidism	0.000502	0.00232	CbGeAlD
Estramustine—ABCB1—cerebellum—hypothyroidism	0.000491	0.00227	CbGeAlD
Estramustine—ESR1—Generic Transcription Pathway—THRA—hypothyroidism	0.000454	0.00758	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—THRA—hypothyroidism	0.000434	0.00723	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—ZNF764—hypothyroidism	0.000339	0.00566	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000324	0.0054	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—PRL—hypothyroidism	0.000316	0.00527	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—NKX2-5—hypothyroidism	0.000309	0.00515	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000297	0.00496	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—THRB—hypothyroidism	0.000293	0.00488	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—THRB—hypothyroidism	0.000279	0.00466	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—THRA—hypothyroidism	0.000219	0.00365	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000157	0.00261	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—NKX2-5—hypothyroidism	0.000156	0.0026	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.00015	0.0025	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—THRB—hypothyroidism	0.000141	0.00235	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00013	0.00216	CbGpPWpGaD
Estramustine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000128	0.00214	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—IYD—hypothyroidism	0.000106	0.00176	CbGpPWpGaD
Estramustine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000104	0.00174	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—ATP5O—hypothyroidism	8.99e-05	0.0015	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—TPO—hypothyroidism	8.46e-05	0.00141	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CLTC—hypothyroidism	8.03e-05	0.00134	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	7.93e-05	0.00132	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TRH—hypothyroidism	6.94e-05	0.00116	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—IYD—hypothyroidism	6.52e-05	0.00109	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	6.26e-05	0.00104	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TSHB—hypothyroidism	6.19e-05	0.00103	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TSHR—hypothyroidism	6.19e-05	0.00103	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ATP5O—hypothyroidism	5.54e-05	0.000925	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—POMC—hypothyroidism	5.52e-05	0.000922	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—SH2B3—hypothyroidism	5.52e-05	0.00092	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—TPO—hypothyroidism	5.21e-05	0.000869	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	4.93e-05	0.000822	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PRL—hypothyroidism	4.09e-05	0.000683	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—TSHB—hypothyroidism	3.92e-05	0.000653	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—VAV3—hypothyroidism	3.79e-05	0.000631	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—AVP—hypothyroidism	3.65e-05	0.000608	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PIK3C2A—hypothyroidism	3.49e-05	0.000582	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—SLC5A5—hypothyroidism	2.93e-05	0.000489	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—POMC—hypothyroidism	2.42e-05	0.000404	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—TSHB—hypothyroidism	2.41e-05	0.000402	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—IGF1—hypothyroidism	2.33e-05	0.000389	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	2.15e-05	0.000359	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—SLC5A5—hypothyroidism	1.81e-05	0.000301	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—POMC—hypothyroidism	1.53e-05	0.000256	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—POMC—hypothyroidism	9.45e-06	0.000158	CbGpPWpGaD
